Westlake Corp Q4 revenue misses on lower sales volume, prices

Westlake

24/02/2026 11:39

Overview

Chemical manufacturer's Q4 revenue missed analyst expectations

Company's Q4 results impacted by lower sales volume and prices, particularly in PEM segment

Outlook

Westlake targets $600 mln EBITDA improvement in PEM for 2026

Company expects HIP segment growth from ACI acquisition in January 2026

Westlake anticipates challenging global industrial conditions in 2026

Result Drivers

PLANT SHUTDOWNS - Significant charges from shutting down chlorovinyls and styrene plants impacted Q4 results

LOWER SALES VOLUME AND PRICES - Declines in sales volume and prices, particularly in PEM, affected Q4 performance

COST REDUCTION INITIATIVES - Company expects cost reduction efforts to improve earnings in 2026

Company press release: ID:nBw3ZkKVQa

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Sales
Miss
$2.53 bln
$2.60 bln (14 Analysts)
Q4 Adjusted EPS
Beat
-$0.25
-$1.43 (16 Analysts)
Q4 EPS
-$4.22
Q4 Net Income
-$544 mln
Q4 EBITDA Margin
8.00%
Q4 Pretax Profit
-$663 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 9 "hold" and 1 "sell" or "strong sell"

The average consensus recommendation for the commodity chemicals peer group is "buy"

Wall Street's median 12-month price target for Westlake Corp is $82.00, about 11.8% below its February 23 closing price of $93.02

The stock recently traded at 156 times the next 12-month earnings vs. a P/E of 60 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)